CluePoints provides Sponsors and CROs a better way of detecting and managing risks that may impact the outcome of clinical trials. Our solutions, all of which are underpinned by Central Statistical Monitoring, a technique that’s being investigated by the FDA for selecting sites for inspection, are deployed to drive a Risk-Based Quality Management strategy, as advocated by ICH and FDA.